PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-κB

Molecules and Cells

Volumn 20, Issue 2, 2005, Pages 241-246

  Choi, Yong Seok ^a   Jeong, Sunjoo ^a  

^a Dankook University   (South Korea)

Author keywords

HDAC1; NF B; p65; PDK 1; PI3 Kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ETOPOSIDE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN P300; PROTEIN SUBUNIT; WORTMANNIN;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOMINANT GENE; DRUG EFFECT; DRUG INHIBITION; ENZYME BINDING; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN DOMAIN; THERAPY RESISTANCE; TRANSCRIPTION INITIATION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; ETOPOSIDE; HELA CELLS; HISTONE DEACETYLASES; HUMANS; MAP KINASE SIGNALING SYSTEM; P300-CBP TRANSCRIPTION FACTORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33645234941     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1109/ICIMW.2005.1572498     Document Type: Article

References (35)

1. Arlt, A., Vorndamm, J., Breitenroich, M., Fölsh, U. R., Kalthoff, H., et al. (2001) Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20, 859-868.
2. Arlt, A., Gehrz, A., Muerkoster, S., Vorndamm, J., Kruse, M. L., et al. (2003) Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22, 3243-3251.
3. Ashburner, B. P., Westerheide, S. D., and Baldwin, A. S. (2001) The p65 (RelA) subunit of NF-kappa B interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21, 7065-7077.
4. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. (1995) Constitutive NF-kappaB activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9, 2736-2746.
5. Chang, J. H., Ryang, Y. S., Morio, T., Lee, S. K., and Chang, E. J. (2004) Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-κB activation, Mol. Cells 18, 177-185.
6. Chen, L. F., Fischle, W., Verdin, E., and Greene, W. C. (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293, 1653-1657.
7. Chen, L. F., Mu, Y., and Greene, W. C. (2002) Acetylation of ReIA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21, 6539-6548.
8. Choi, Y. S. and Jeong, S. (2004) New paradigm for the NF-κB transcriptional regulation. J. Nano. Bio. Tech. 1, 21-27.
9. Ghosh, S. (1999) Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol. Res. 19, 183-189.
10. Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
11. Ibuki, Y. and Goto, R. (2000) Suppression of apoptosis by UVB irradiation: survival signaling via PI3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 279, 872-878.
12. Karin, A., Cao, Y., Greten, F. R., and Li, Z.-W. (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. 2, 301-310.
13. Kim, D. and Chung, J. (2002) Akt: versatile mediator of cell survival and beyond. J. Biochem. Mol. Biol. 35, 106-115.
14. Lim, M. A., Kikani, C. K., Wick, M. J., and Dong, L. Q. (2003) Nuclear translocation of 3′-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. Proc. Natl. Acad. Sci. USA 100, 14006-14011.
15. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin, A. S., et al. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20, 1626-1638.
16. Madrid, L. V., Mayo, M. W., Reuther, J. Y., and Baldwin, A. S. (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940.
17. Mayo, M. W., Madrid, L. V., Westerheide, S. D., Jones, D. R., Yuan, X. J., et al. (2002) PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J. Biol. Chem. 277, 11116-11125.
18. Mayo, M. W., Denliger, C. E., Broad, R. M., Yeung, F., Reilly, E. T., et al. (2003) Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J. Biol. Chem. 278, 18980-18989.
19. Mitchell, T. and Sugden, B. (1995) Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69, 2968-2976.
20. Okazaki, T., Sakon, S., Sasazuki, T., Sakurai, H., Doi, T., et al. (2003) Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300, 807-812.
21. Osaki, M., Oshimura, M., and Ito, H. (2004) PI3K-Akt pathway: its function and alterations in human cancer. Apoptosis 9, 667-676.
22. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
23. Reddy, S. A., Huang, J. H., and Liao, W. S. (2000) Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation. J. Immunol. 164, 1355-1363.
24. Romashkova, J. and Makarov, S. S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401, 86-89.
25. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W. (1999) IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356.
26. Scheid, M. P. and Woodgett, J. R. (2003) Unravelling the activation mechanism of protein kinase B/Akt. FEBS Lett. 546, 108-112.
27. Schmitz, M., Mattioli, I., Buss, H., and Kracht, M. (2004) NF-B: a multifaceted transcription factor regulated at several levels. ChemBioChem. 5, 1348-1358.
28. Shishodia, S. and Aggarwal, B. B. (2004) Nuclear factor-κB: a friend or a foe in cancer? Biochem. Pharmacol. 68, 1071-1080.
29. Sizemore, N., Leung, S., and Stark, G. R. (1999) Activation of phosphatidylinositol 3-kinase in response to Interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 19, 4798-4805.
30. Torker, A. (2000) Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57, 652-658.
31. Toker, A. and Newton, A. (2000) Cellular signaling: pivotaling around PDK-1. Cell 103, 185-188.
32. 529 is controlled by casein kinase II. J. Biol. Chem. 275, 32592-32597.
33. Watanabe, K., Kubota, M., Hamahata, K., Lin, Y. W., and Usami, I. (2002) Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappaB activation. Biochem. Pharmacol. 60, 823-830.
34. Zhong, H., Voll, R. E., and Ghosh, S. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-671.
35. Zhong, H., May, M. J., Jimi, E., and Ghosh, S. (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636.